Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Esperion Therapeutics (ESPR) has a market cap of $0.20 billion USD. According to our data, Esperion Therapeutics is ranked No.7000 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.20 B |
-54.55%
|
| Dec 31, 2024 | $0.43 B |
-26.42%
|
| Dec 29, 2023 | $0.59 B |
-52.01%
|
| Dec 30, 2022 | $1.23 B |
24.60%
|
| Dec 31, 2021 | $0.99 B |
-80.77%
|
| Dec 31, 2020 | $5.12 B |
-56.40%
|
| Dec 31, 2019 | $11.75 B |
29.63%
|
| Dec 31, 2018 | $9.06 B |
-30.13%
|
| Dec 29, 2017 | $12.97 B |
425.88%
|
| Dec 30, 2016 | $2.47 B |
-43.76%
|
| Dec 31, 2015 | $4.39 B |
-44.96%
|
| Dec 31, 2014 | $7.97 B |
194.32%
|
| Dec 31, 2013 | $2.71 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
| Market Cap | = | ESPR Stock Price | * | ESPR Shares Outstanding |
| = | $1.00 | * | 0.20 B | |
| = | $0.20 B |